![](/img/cover-not-exists.png)
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy
David J. Shiling, Richard C. Stillman, Alfred E. Chang, Nelson H. Goldberg, Claudia A. Seipp, Ivan Barofsky, Steven A. RosenbergVolume:
47
Year:
1981
Language:
english
Pages:
6
DOI:
10.1002/1097-0142(19810401)47:73.0.co;2-4
File:
PDF, 440 KB
english, 1981